Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Alzheimer’s Disease

memantine1 - general anesthesia1 - lack of concentration1 - quality of care2 - alcoholism1 - early-onset alzheimer's1 - fibrous tangles1 - brain injury1 - coffee consumption1 - cardiovascular disease1 - psychiatric status rating scales1 - islet amyloid polypeptide1 - thyroid disease1 - inheritable dominant disease1 - amyloid beta peptide1 - parkinson disease3 - amyloid hypothesis1 - imbeciles1 - senility1 - genomic dna1 - disinhibition1 - hiv dementia1 - amnesia1 - korsakoff syndrome3 - carus1 - psychometrics1 - cvd1 - sage test1 - prevent dementia4 - late-day anxiety1 -